Elite Diagnostic Limited (JMSE:ELITE)
Jamaica · Delayed Price · Currency is JMD 1.300
-0.010 (-0.76%)
At close: Aug 14, 2026
Elite Diagnostic Cash Flow Statement
Financials in millions JMD. Fiscal year is July - June.
Millions JMD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | 31.51 | 32.02 | 26.16 | 13.35 | 48.66 |
Depreciation & Amortization | 179.38 | 166.19 | 132.16 | 136.5 | 104.93 |
Other Amortization | - | 3.92 | 3.07 | -0.06 | 2.59 |
Other Operating Activities | -8.5 | 0.28 | 3.04 | -0.06 | -0.01 |
Change in Accounts Receivable | -5.98 | 57.09 | -25.85 | -57.22 | -17.5 |
Change in Inventory | -15.59 | - | - | - | - |
Change in Accounts Payable | -34.61 | 3.66 | 18.17 | 29.88 | 9.56 |
Change in Other Net Operating Assets | -1.6 | -2.59 | 8.07 | -10.51 | -0.32 |
Operating Cash Flow | 144.61 | 260.57 | 164.81 | 111.88 | 147.92 |
Operating Cash Flow Growth | -44.50% | 58.10% | 47.31% | -24.36% | 18.29% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -436.85 | -92.62 | -72.53 | -137.75 | -275.79 |
Other Investing Activities | 1.28 | 0.13 | 0.09 | -20.41 | 0.01 |
Investing Cash Flow | -435.57 | -92.49 | -72.44 | -158.15 | -275.78 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Short-Term Debt Issued | 230.41 | 9.74 | 14.09 | 9.14 | 5.83 |
Long-Term Debt Issued | - | 400 | - | 365.42 | 190 |
Total Debt Issued | 230.41 | 409.74 | 14.09 | 374.56 | 195.83 |
Short-Term Debt Repaid | -9.67 | -11.57 | -10.52 | -8.37 | - |
Long-Term Debt Repaid | -31.17 | -377.92 | -112.6 | -334.86 | -24.26 |
Total Debt Repaid | -40.83 | -389.49 | -123.12 | -343.23 | -24.26 |
Net Debt Issued (Repaid) | 189.57 | 20.25 | -109.04 | 31.33 | 171.57 |
Common Dividends Paid | - | - | - | -7.07 | -31.81 |
Financing Cash Flow | 189.57 | 20.25 | -109.04 | 24.27 | 139.76 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Cash Flow | -101.39 | 188.33 | -16.66 | -22.01 | 11.9 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -292.24 | 167.95 | 92.29 | -25.87 | -127.87 |
Free Cash Flow Growth | - | 81.98% | - | - | - |
Free Cash Flow Margin | -33.70% | 19.67% | 11.24% | -3.43% | -20.48% |
Free Cash Flow Per Share | -0.83 | 0.47 | 0.26 | -0.07 | -0.36 |
Levered Free Cash Flow | -324.49 | 163.65 | 93.6 | -19.1 | -142.07 |
Unlevered Free Cash Flow | -294.29 | 181.3 | 124 | 1.32 | -124.99 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | - | 39.14 | 62.79 | 46.87 | 27.33 |
Cash Income Tax Paid | - | 0.31 | 0.07 | - | - |
Change in Working Capital | -57.78 | 58.16 | 0.39 | -37.86 | -8.26 |